Status:

UNKNOWN

The Early Nasojejunal Tube to Meet Energy Requirements in Intensive Care (ENTERIC) Study

Lead Sponsor:

Bayside Health

Conditions:

Critical Illness

Malabsorption Syndromes

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This is a multi-centre randomised controlled trial comparing early jejunal feeding (using a frictional nasojejunal \[NJ\] tube) and standard feeding in critical illness.

Eligibility Criteria

Inclusion

  • ICU patients are eligible for enrolment if they meet all of the following:
  • Age \> 18 years old
  • In ICU for \< 48 hours prior to enrolment
  • Receiving invasive mechanical ventilation (through an endotracheal tube or tracheostomy, but NOT a facemask) with an anticipated need for \> 48 hours of mechanical ventilation
  • Receiving a continuous infusion of any one of:
  • morphine \> 2 mg/hour,
  • fentanyl \> 20 mcg/hour, or
  • pethidine \> 20 mg/hour
  • Either a single GRV \> 150 mls (whilst receiving EN via a NG tube) or nasogastric drainage \> 500 mls over 12 hours (whether receiving EN or not)

Exclusion

  • Patients will be ineligible for enrolment if they meet any of the following:
  • Previous or recent surgery which has altered the anatomy of the upper gastrointestinal tract (eg. oesophagectomy, gastrectomy, any gastric anastomosis surgery, gastroplasty, pyloroplasty, pancreaticoduodenectomy \[Whipple's procedure\])
  • Known gastric malignancy
  • Known oesophageal varices
  • Current admission for peptic ulceration
  • Current mechanical bowel obstruction
  • Current gastrostomy, jejunostomy, or surgically-placed enteral tube in situ
  • Contraindication to the use of the nose and mouth for enteral tube insertion (eg. recent facial trauma or surgery)
  • Receiving nutritional support prior to ICU admission
  • Severe coagulopathy (defined by platelet count \< 20 and/or international normalized ratio \[INR\] \> 4.0)

Key Trial Info

Start Date :

Trial Type :

INTERVENTIONAL

End Date :

Estimated Enrollment :

180 Patients enrolled

Trial Details

Trial ID

NCT00163813

Last Update

February 26 2007

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Alfred Hospital

Melbourne, Victoria, Australia, 3181